Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)

S. Zovato, A. Kumanova, S. Demattè, M. Sansovini, L. Bodei, D. Di Sarra, E. Casagranda, S. Severi, A. Ambrosetti, F. Schiavi, G. Opocher, G. Paganelli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds